Small Molecules
11 March 2019
Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine11 March 2019
Navitor Pharmaceuticals Announces Peer-Reviewed Publication Detailing the Discovery and Development of NV-513811 March 2019
Tenax Therapeutics Enrolls First Patient for Phase 2 Pulmonary Hypertension Clinical Trial11 March 2019
Celgene Submits Application to EMA for Ozanimod for the Treatment of Relapsing-Remitting Multiple Sclerosis10 March 2019
Forendo Pharma Successfully Completes Phase 1a Clinical Trial of FOR-6219 for the Treatment of EndometriosisNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports